DR. MATTHEW PHILIP FROSCH, MD PHD
Medical Practice in Boston, MA

License number
Massachusetts 60150
Category
Medical Practice
Type
Neuropathology
License number
Massachusetts 60150
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
55 Pathology Associates, Boston, MA 02114
Phone
(617) 726-1265
(617) 724-1813 (Fax)
(617) 724-0287
(617) 726-2894 (Fax)

Professional information

Matthew Philip Frosch Photo 1

Matthew Philip Frosch, Boston MA

Specialties:
Pathology, Anatomic Pathology, Neuropathology, Anatomic Pathology & Clinical Pathology
Work:
Massachusetts General Hospital
55 Fruit St, Boston, MA 02114
Education:
Harvard University(1987)


Matthew Philip Frosch Photo 2

Matthew Philip Frosch, Boston MA

Specialties:
Pathologist
Address:
55 Fruit St, Boston, MA 02114
Education:
Harvard Medical School - Doctor of Medicine
Harvard University - Doctor of Philosophy
Brigham & Women's Hospital - Residency - Pathology
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology), American Board of Pathology Sub-certificate in Neuropathology (Pathology)


Matthew P Frosch Photo 3

Dr. Matthew P Frosch, Boston MA - MD (Doctor of Medicine)

Specialties:
Neuropathology
Address:
55 Fruit St, Boston 02114
Massachusetts General Hosp Path
55 Fruit St STE 2, Boston 02114
(617) 726-2967 (Phone)
Certifications:
Anatomic Pathology, 1992, Neuropathology, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
55 Fruit St, Boston 02114
Massachusetts General Hosp Path
55 Fruit St STE 2, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
Education:
Medical School
Harvard Med Sch
Graduated: 1987
Brigham and Womens Hospital
Brigham & Women's Hosp/Children's Hosp


Matthew Frosch Photo 4

Methods For Treating Acat-Related Diseases

US Patent:
2005011, Jun 2, 2005
Filed:
Nov 8, 2004
Appl. No.:
10/983969
Inventors:
Dora Kovacs - Charlestown MA, US
Luigi Puglielli - Madison WI, US
Rudolph Tanzi - Hull MA, US
Matthew Frosch - Charlestown MA, US
International Classification:
A61K031/4965, A61K009/22
US Classification:
424423000, 604890100
Abstract:
The invention relates to methods for administering inhibitors of acyl-coenzyme A:cholesterol acyltransferase (ACAT) activity, and for treating Alzheimer's disease, atherosclerosis, and other ACAT-related diseases. The invention also relates to sustained release delivery systems.